Related Experiment Video
Updated: Mar 26, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
[Evaluation of physical development in children with classical phenylketonuria]
Insights
Modern infant formulas for phenylketonuria (PKU) improve physical development. Early treatment with phenylalanine-free amino acid mixtures supports healthy growth in children with PKU, unlike older protein hydrolysate formulas.
Area of Science:
- Biochemistry
- Pediatrics
- Genetics
Context:
- Phenylketonuria (PKU) is an inherited metabolic disorder affecting phenylalanine metabolism.
- Dietary management, specifically a low-phenylalanine diet, is crucial for PKU patients.
- Long-term protein restriction can impede growth and physical development in PKU individuals.
Purpose:
- To assess the physical development of classical PKU patients at birth and during dietary treatment.
- To compare the impact of different phenylalanine-free diet compositions on PKU patient growth.
- To evaluate the effectiveness of modern amino acid mixtures versus older protein hydrolysates.
Summary:
- A study analyzed 257 PKU patients using WHO Anthroplus 2009, comparing growth outcomes between those on protein hydrolysates (1980-1993) and amino acid mixtures (1995-2012).
- Initial BMI Z-scores were comparable, but after 6 months, patients on modern amino acid mixtures showed significantly higher normal BMI Z-scores (95.6%) versus those on protein hydrolysates (71.3%).
- Modern phenylalanine-free amino acid mixtures, enriched with essential nutrients, promote normal physical development in PKU patients.
Impact:
- Highlights the importance of nutrient-enriched, phenylalanine-free formulas for optimal PKU management.
- Suggests a shift towards contemporary amino acid-based diets for improved pediatric growth outcomes in PKU.
- Provides evidence for enhanced physical development in PKU patients using advanced dietary interventions.
Abstract:
Classical phenylketonuria (PKU) is hereditary disease, which is based on the disturbance of phenylalanine conversion to tyrosine. The basic treatment of PKU is low phenylalanine diet. Prolonged restriction of natural protein may have a negative impact to PKU patient growth and physical development. The objective was to evaluate the physical development of patients with classical PKU at birth and on the diet based on the products with different chemical composition without phenylalanine. 257 PKU patients have been examined with the computer program "WHO Anthroplus 2009". All patient were born at term. Z-score of body weight, height and body mass index (BMI) to age has been retrospectively estimated. Patients were divided into 2 groups: group 1--101 children born in 1980-1993 were fed by unadapted specialty products based on protein hydrolyzate with restricted phenylalanine, and group 2--156 children born in 1995-2012 were fed by contemporary amino acid mixtures without phenylalanine. All newborn PKU patients had the middle for age Z-score of weight and BMI, 21% of neonates had high Z-score growth. Before the diet therapy BMI Z-score was normal in 84.1% patients in group 1 and 87.2% patients of group 2. After 6 mo of treatment with low phenylalanine diet the number of patient with normal BMI Z-score was 71.3% in group 1 against 95.6% in group 2. Thus, using of modern amino acid mixtures without phenylalanine, enriched with essential nutrients can promote the normal physical development of PKU patients.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Related Concept Videos
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pedigree Analysis